Skip to main content
. 2023 Oct 2;133(19):e164918. doi: 10.1172/JCI164918

Figure 7. Plerixafor and G-CSF effects on wart burden in patients with WHIM.

Figure 7

Representative images of warts at baseline and at the end of the indicated drug treatment period are shown for patients demonstrating improvement in wart areas during the study. Images are for the patient indicated to the left of the corresponding row. Comprehensive assessments of wart changes on drug treatment are detailed in Table 2, Supplemental Tables 7–13, and Supplemental Figure 7.